Registered Kenya · PPB

TUBERCULIN PPD RT 23 SSI

TUBERCULIN

11203 2TU INN generic

What it does

Tuberculin is a substance used in skin tests to check for tuberculosis (TB) infection.

Commonly used for: tuberculosis infection (TB)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
11203
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
TUBERCULIN
Dosage form
2TU
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Caroga Pharma
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Addis Ababa, Ethiopia

Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:09:56 · updated 2026-03-23 04:55:07

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Tuberculin is a substance used in skin tests to check for tuberculosis (TB) infection.

What it treats

  • tuberculosis infection (TB)

How it works

Tuberculin helps identify if someone has been exposed to the bacteria that cause TB by causing a reaction in the skin.

Who it's for

It is used for people who may have been exposed to tuberculosis or are at risk of TB.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: tuberculin

Tuberculin is a purified protein derivative (PPD) used primarily in the diagnosis of tuberculosis (TB). It is derived from the culture filtrates of Mycobacterium tuberculosis and is administered intradermally to elicit an immune response in individuals who have been exposed to the bacteria. The standard test for tuberculin is the Mantoux test, which measures the induration produced by the immune response at the injection site after 48 to 72 hours.

Indications

  • Diagnosis of tuberculosis infection
  • Screening for latent tuberculosis
  • Assessment of immune response in individuals at risk for TB

Dosage

Children: Refer to the BNF for Children for specific dosing information, as it may vary based on the test protocol and local recommendations.

Adults: Refer to clinical guidelines for specific dosing information, as it may vary based on the test protocol and local recommendations.

Mechanism of action

Tuberculin works by stimulating a delayed-type hypersensitivity reaction mediated by T lymphocytes. When tuberculin is injected, it interacts with specific T cells that have previously been sensitized to Mycobacterium tuberculosis antigens. This leads to the release of cytokines and the recruitment of inflammatory cells to the site, resulting in the characteristic induration seen in a positive test.

Pharmacodynamics

The pharmacodynamic effect of tuberculin is the elicitation of a localized immune response, specifically a type IV hypersensitivity reaction. This response is specific to individuals who have had prior exposure to TB, either through infection or vaccination with the Bacillus Calmette-Guérin (BCG) vaccine. The size of the induration correlates with the degree of sensitization and potential exposure to TB.

Pharmacokinetics

The pharmacokinetics of tuberculin are less well defined since it is not absorbed systemically in the same way as conventional drugs. Following intradermal administration, tuberculin remains localized at the injection site, where it interacts with local immune cells. The peak response typically occurs within 48 to 72 hours, after which the induration may resolve over several days to weeks.

Contra-indications

  • History of severe allergic reaction to tuberculin or any component of the formulation
  • Active tuberculosis infection

Adverse effects

  • Local reactions at the injection site such as redness, swelling, or itching
  • Fever
  • Malaise
  • Rarely, systemic allergic reactions

Interactions

  • Immunosuppressive therapies may affect the response to tuberculin skin testing
  • Bacillus Calmette-Guérin (BCG) vaccine may lead to false-positive results

Precautions

  • Use with caution in individuals with a history of hypersensitivity reactions
  • Consider the potential for false-negative results in immunocompromised patients

Pregnancy

No specific contraindications have been established, but consult healthcare providers regarding the benefits and risks.

Breast-feeding

Generally considered safe, but consult healthcare providers for individual assessment.

Storage

Store at 2-8°C. Do not freeze. Protect from light.

Formulations

  • Tuberculin purified protein derivative (PPD) for intradermal administration

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.